FMRL
Karachi, Sindh, Pakistan
NCT Number: NCT06809504
OT emphasis lies within the scope of improving daily life activities, cognitive and physical performance in order to regain the proper social role. This work assesses the impact of a 12 session structured OT intervention program for patients with SUD in IPD. Benefitting from checklists like the Montreal Cognitive Assessment (MoCA), the Barthel Index, the Lawton-Brody IADLs scale, it substantiates attaining enhancements in expressive cognitive functions, ADLs, and IADLs to understand how selected OT intervention modalities can enhance functional capabilities.
Looking for future studies?
Notify MeUp to 55 year
All sexes
Interventional
Not applicable
Karachi, Sindh, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12 sessions over 4 weeks, 45-minute sessions divided into:
o 15 minutes for physical exercises
Time frame: baseline and after 12 weeks of intervention
The MoCA offers assessment of many cognitive aspects, it presents assessments for attention, memory, language, visual construction, executive functions, and orientation.
Hammad Mursaleen
Other
Restoring Functionality: Occupational Therapy Interventions in Substance Use Drug Rehabilitation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07590154
Addiction, Behavior
Ajijic, Jalisco, Mexico
View Trial DetailsNCT07088770
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kingston, New York, United States
View Trial DetailsNCT06652269
Anxiety, Anxiety Disorders
Kosmonosy, Czechia
View Trial DetailsNCT02222909
Cardiovascular Disease, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial Details